These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8589260)
21. [Expression of synthetic human interleukin-10 gene and its mutant variants in Escherichia coli cells]. Ptitsyn LR; Al'tman IB; Gurov MV Bioorg Khim; 1998 Jan; 24(1):48-57. PubMed ID: 9551202 [TBL] [Abstract][Full Text] [Related]
22. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599 [TBL] [Abstract][Full Text] [Related]
23. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis. Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997 [TBL] [Abstract][Full Text] [Related]
24. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis. Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910 [TBL] [Abstract][Full Text] [Related]
25. An Escherichia coli expression vector that allows recovery of proteins with native N-termini from purified calmodulin-binding peptide fusions. Wyborski DL; Bauer JC; Zheng CF; Felts K; Vaillancourt P Protein Expr Purif; 1999 Jun; 16(1):1-10. PubMed ID: 10336854 [TBL] [Abstract][Full Text] [Related]
26. Long loop residues 33-58 in the human glycoprotein hormone common alpha subunit contain structural components for subunit heterodimerization and human follitropin-receptor binding. Liu C; Dias JA Arch Biochem Biophys; 1996 May; 329(1):127-35. PubMed ID: 8619629 [TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the thermostable arginine repressor from Bacillus stearothermophilus: dissecting residues involved in DNA binding properties. Karaivanova IM; Weigel P; Takahashi M; Fort C; Versavaud A; Van Duyne G; Charlier D; Hallet JN; Glansdorff N; Sakanyan V J Mol Biol; 1999 Aug; 291(4):843-55. PubMed ID: 10452892 [TBL] [Abstract][Full Text] [Related]
28. A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells. Ruzek MC; Billadeau D; Mathur A J Immunol; 1996 Mar; 156(6):2124-32. PubMed ID: 8690901 [TBL] [Abstract][Full Text] [Related]
29. Are turns required for the folding of ribonuclease T1? Garrett JB; Mullins LS; Raushel FM Protein Sci; 1996 Feb; 5(2):204-11. PubMed ID: 8745397 [TBL] [Abstract][Full Text] [Related]
30. A fully active variant of dihydrofolate reductase with a circularly permuted sequence. Buchwalder A; Szadkowski H; Kirschner K Biochemistry; 1992 Feb; 31(6):1621-30. PubMed ID: 1737018 [TBL] [Abstract][Full Text] [Related]
31. Circularly permuted dihydrofolate reductase of E. coli has functional activity and a destabilized tertiary structure. Protasova NYu ; Kireeva ML; Murzina NV; Murzin AG; Uversky VN; Gryaznova OI; Gudkov AT Protein Eng; 1994 Nov; 7(11):1373-7. PubMed ID: 7700869 [TBL] [Abstract][Full Text] [Related]
32. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Ryan JJ; McReynolds LJ; Keegan A; Wang LH; Garfein E; Rothman P; Nelms K; Paul WE Immunity; 1996 Feb; 4(2):123-32. PubMed ID: 8624803 [TBL] [Abstract][Full Text] [Related]
33. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. Kruse N; Shen BJ; Arnold S; Tony HP; Müller T; Sebald W EMBO J; 1993 Dec; 12(13):5121-9. PubMed ID: 8262056 [TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship study of human interleukin-3. Identification of residues required for biological activity by site-directed mutagenesis. Lokker NA; Movva NR; Strittmatter U; Fagg B; Zenke G J Biol Chem; 1991 Jun; 266(16):10624-31. PubMed ID: 2037601 [TBL] [Abstract][Full Text] [Related]
35. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. Morrison BW; Leder P J Biol Chem; 1992 Jun; 267(17):11957-63. PubMed ID: 1601864 [TBL] [Abstract][Full Text] [Related]
36. Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini. Horlick RA; George HJ; Cooke GM; Tritch RJ; Newton RC; Dwivedi A; Lischwe M; Salemme FR; Weber PC; Horuk R Protein Eng; 1992 Jul; 5(5):427-31. PubMed ID: 1518791 [TBL] [Abstract][Full Text] [Related]
37. Fusion protein of interleukin 4 and diphtherial toxin with high cytotoxicity to cancer cells. Zhang YJ; Hu XB; Li SX; Tian LP; Yang SL; Gong Y Acta Biochim Biophys Sin (Shanghai); 2004 Jun; 36(6):437-42. PubMed ID: 15188060 [TBL] [Abstract][Full Text] [Related]
38. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. Kruse N; Tony HP; Sebald W EMBO J; 1992 Sep; 11(9):3237-44. PubMed ID: 1387082 [TBL] [Abstract][Full Text] [Related]
39. Overexpression and structure--function analysis of a bioengineered IL-2/IL-6 chimeric lymphokine. Rock F; Everett M; Klein M Protein Eng; 1992 Sep; 5(6):583-91. PubMed ID: 1438170 [TBL] [Abstract][Full Text] [Related]
40. Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency. Berndt WG; Chang DZ; Smith KA; Ciardelli TL Biochemistry; 1994 May; 33(21):6571-7. PubMed ID: 8204593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]